ImmuNet Zoominar: Drs. Matthias Götte & Joanne Lemieux, Sep 24, 10am

COVID-19 drug development research updates. (Not yet in ImmuNet? - get zoom link & password from ddoudiet@ualberta.ca)

23 September 2020

Thursday, September 24, 2020  10:00 am

Current COVID-19 Research Updates

 

Dr. Matthias Götte,

Professor & Chair, Department of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, University of Alberta

"Remdesivir: From Mechanisms and Antiviral Effects to Clinical Approval for Treatment of COVID-19"

 

Dr. Joanne Lemieux,

Professor, Director, Membrane Protein Disease Research Group, Department of Biochemistry, Faculty of Medicine & Dentistry, University of Alberta

"Structural insights into the feline coronavirus drug GC376, which inhibits the main protease of SARS-CoV-2 and blocks virus replication"